Chirata: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Chirata (Swertia chirayita) is a plant known for its bitter taste. It's native to the Himalayan region and traditionally used as medicine.

Chirata contains chemicals that may fight some bacteria, viruses, and fungi. It might also have effects that lower blood sugar.

People use chirata for asthma, diabetes, hepatitis, upset stomach, high blood pressure, and many other conditions, but there is no good scientific evidence to support these uses.

Uses & Effectiveness

We currently have no information for Chirata overview.

Side Effects

When taken by mouth: Chirata is commonly consumed in foods. But there isn't enough reliable information to know if chirata is safe when taken in larger amounts as medicine or what the side effects might be.

Special Precautions and Warnings

Pregnancy and breast-feeding: There isn't enough reliable information to know if chirata is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.

Intestinal ulcers. Chirata might make ulcers in the intestine worse.

Surgery. Chirata might lower blood sugar. This might interfere with blood sugar control during and after surgical procedures. Stop using chirata as a medicine at least two weeks before a scheduled surgery.

Interactions

Moderate Interaction

Be cautious with this combination

Medications for diabetes (Antidiabetes drugs) interacts with Chirata
Chirata might lower blood sugar levels. Taking chirata along with diabetes medications might cause blood sugar to drop too low. Monitor your blood sugar closely.

Dosing

There isn't enough reliable information to know what an appropriate dose of chirata might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.

View References

REFERENCES:

Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.

Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

Williamson EM, Evans FJ, eds. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Essex, England: CW Daniel Company Ltd., 1998.

Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

Scartezzini, P. and Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000;71(1-2):23-43.

Karan, M., Vasisht, K., and Handa, S. S. Antihepatotoxic activity of Swertia chirata on carbon tetrachloride induced hepatotoxicity in rats. Phytother.Res. 1999;13(1):24-30.

Karan, M., Vasisht, K., and Handa, S. S. Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats. Phytother.Res. 1999;13(2):95-101.

Medda, S., Mukhopadhyay, S., and Basu, M. K. Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J.Antimicrob.Chemother. 1999;44(6):791-794.

Khanom, F., Kayahara, H., and Tadasa, K. Tyrosinase inhibitory activity of Bangladeshi indigenous medicinal plants. Biosci.Biotechnol.Biochem. 2000;64(9):1967-1969.

Reen, R. K., Karan, M., Singh, K., Karan, V., Johri, R. K., and Singh, J. Screening of various Swertia species extracts in primary monolayer cultures of rat hepatocytes against carbon tetrachloride- and paracetamol-induced toxicity. J.Ethnopharmacol. 2001;75(2-3):239-247.

Prashanth, D., Amit, A., Samiulla, D. S., Asha, M. K., and Padmaja, R. alpha-Glucosidase inhibitory activity of Mangifera indica bark. Fitoterapia 2001;72(6):686-688.

Saha, P. and Das, S. Regulation of hazardous exposure by protective exposure: modulation of phase II detoxification and lipid peroxidation by Camellia sinensis and Swertia chirata. Teratog.Carcinog.Mutagen. 2003;Suppl 1:313-322.

Saha, P., Mandal, S., Das, A., Das, P. C., and Das, S. Evaluation of the anticarcinogenic activity of Swertia chirata Buch.Ham, an Indian medicinal plant, on DMBA-induced mouse skin carcinogenesis model. Phytother.Res. 2004;18(5):373-378.

Saha, P., Mandal, S., Das, A., and Das, S. Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model. Cancer Lett. 12-8-2006;244(2):252-259.

Iqbal, Z., Lateef, M., Khan, M. N., Jabbar, A., and Akhtar, M. S. Anthelmintic activity of Swertia chirata against gastrointestinal nematodes of sheep. Fitoterapia 2006;77(6):463-465.

Suryawanshi, S., Mehrotra, N., Asthana, R. K., and Gupta, R. C. Liquid chromatography/tandem mass spectrometric study and analysis of xanthone and secoiridoid glycoside composition of Swertia chirata, a potent antidiabetic. Rapid Commun.Mass Spectrom. 2006;20(24):3761-3768.

Suryawanshi, S., Asthana, R. K., and Gupta, R. C. Simultaneous estimation of mangiferin and four secoiridoid glycosides in rat plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study of herbal preparation. J.Chromatogr.B Analyt.Technol.Biomed.Life Sci. 10-15-2007;858(1-2):211-219.

Verma, H., Patil, P. R., Kolhapure, R. M., and Gopalkrishna, V. Antiviral activity of the Indian medicinal plant extract Swertia chirata against herpes simplex viruses: a study by in-vitro and molecular approach. Indian J.Med.Microbiol. 2008;26(4):322-326.

Suryawanshi, S., Asthana, R. K., and Gupta, R. C. Assessment of systemic interaction between Swertia chirata extract and its Bioactive constituents in rabbits. Phytother.Res. 2009;23(7):1036-1038.

Sekar, B. C., Mukherjee, B., Chakravarti, R. B., and Mukherjee, S. K. Effect of different fractions of Swertia chirayita on the blood sugar level of albino rats. J.Ethnopharmacol. 1987;21(2):175-181.

Rafatullah, S., Tariq, M., Mossa, J. S., al-Yahya, M. A., al-Said, M. S., and Ageel, A. M. Protective effect of Swertia chirata against indomethacin and other ulcerogenic agent-induced gastric ulcers. Drugs Exp.Clin.Res. 1993;19(2):69-73.

Ray, S., Majumder, H. K., Chakravarty, A. K., Mukhopadhyay, S., Gil, R. R., and Cordell, G. A. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani. J.Nat.Prod. 1996;59(1):27-29.

Mukherjee, S., Sur, A., and Maiti, B. R. Hepatoprotective effect of Swertia chirata on rat. Indian J.Exp.Biol. 1997;35(4):384-388.

Bhattacharya, S. K., Reddy, P. K., Ghosal, S., Singh, A. K., and Sharma, P. V. Chemical constituents of Gentianaceae XIX: CNS-depressant effects of swertiamarin. J.Pharm.Sci. 1976;65(10):1547-1549.

Joshi P, Dhawan V. Swertia chirayita - an overview. CURRENT SCIENCE 8-25-2005;89(4):635-640.

Rai LK, Prasad P Sharma E. Conservation threats to some important medicinal plants of the Sikkim Himalaya. BIOLOGICAL CONSERVATION 2000;93(1):27-33.

Pant N, Jain DC Bhakuni RS. Some chemical constituents of Swertia chirata. INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY 2002;41(9):1980-1986.

Awasthi AK, Bisht GS Anroop B. In vitro antimicrobial activity of Swertia chirata. Indian Journal of Natural Products 2005;21:27-29.

Rawat MSM, Dutt KR. Comparison of ethyl acetate extracts of Allium cepa bulbs, Luffa acutangula fruits, Nyctanthes arbostristis leaves, Swertia chirata twigs and Woodfordia floribunda leaves with Silymarin for hepatoprotective activity. PLANT ARCHIVES 2007;7(1):183-186.

Rao TVRK, Das M. In-vitro inhibition of mineralisation of urinary stone forming minerals by some medicinal plant extracts. ASIAN JOURNAL OF CHEMISTRY 2000;12(3):719-722.

Mukherjee B, Mukherjee SK. Blood sugar lowering activity of Swertia chirata (Buch.-Ham.) extract. Int.J.Crude Drug Res. 1987;25:97-102.

Manjunath KP, Shivakumar H Prakash T Patil KS Rao RN et al. Anthelmintic activity of roots of <it>Swertia chirata</it>. Indian Journal of Natural Products 2006;22:8-10.

Hussain AI, Anwar F Bhatti HN Rashid U. Phytochemical and in vitro anthelmintic screening of Butea frondosa and Swertia chirata from Pakistan. JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN 2006;28(1):84-92.

Singha UK, Guru PY Sen AB Tandon JS. Antileishmanial activity of traditional plants against Leishmania donovani in golden hamsters. International Journal of Pharmacognosy 1992;30:289-295.

Madhuri S, Pandey G. Some dietary agricultural plants with anticancer properties. PLANT ARCHIVES 2008;8(1):13-16.

Gowadia N, Vasudevan TN. Studies on effect of some medicinal plants on pancreatic lipase activity using spectrophotometric method. ASIAN JOURNAL OF CHEMISTRY 2000;12(3):847-852.

CHAKRAVARTY AK, MUKHOPADHYAY S MOITRA SK DAS B. (-)-SYRINGARESINOL, A HEPATOPROTECTIVE AGENT AND OTHER CONSTITUENTS FROM SWERTIA-CHIRATA. INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY 1994;33(4):405-408.

Tripathi R, Mohan H Kamat JP. Modulation of oxidative damage by natural products. FOOD CHEMISTRY 2007;100(1):81-90.

Anon. Bitter fraction of Swertia chirata can prevent carcinogenic risk due to DMBA exposure. INDIAN JOURNAL OF MEDICAL RESEARCH 2005;121:135.

DALAL SR, SHAH RC. SWERCHIRIN, A NEW XANTHONE FROM SWERTIA-CHIRATA. CHEMISTRY & INDUSTRY 1956;26:664.

CHAKRAVARTY AK, MUKHOPADHYAY S DAS B. SWERTANE TRITERPENOIDS FROM SWERTIA-CHIRATA. PHYTOCHEMISTRY 1991;30(12):4087-4092.

BENNAROCHE L, VERNEY AM DEFAYE G DEBELMAS AM. TRITERPENES OF GENTIANACEES - SWERTIA-CHIRATA HAM. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D 1975;280(21):2493-2495.

Bhandari P, Kumar N Gupta AP Singh B Kaul VK. Micro-LC determination of swertiamarin in Swertia species and bacoside-A in Bacopa monnieri. CHROMATOGRAPHIA 2006;64(9-10):599-602.

Sharma PV. Alkaloids of Swertia chirata Buch.-Ham. Indian Journal of Pharmaceutical Sciences 1982;44:36.

CHAUDHURI PK, DANIEWSKI WM. UNAMBIGUOUS ASSIGNMENTS OF THE H-1 AND C-13 CHEMICAL-SHIFTS OF THE MAJOR BITTER PRINCIPLE OF SWERTIA-CHIRATA BY 2D NMR-STUDY AND CHARACTERIZATION OF OTHER CONSTITUENTS. POLISH JOURNAL OF CHEMISTRY 1995;69(11):1514-1519.

Ahmmed SM, Mukherjee PK, Bahadur S, Harwansh RK, Kar A, Bandyopadhyay A, et al. CYP450 mediated inhibition potential of Swertia chirata: An herb from Indian traditional medicine. J Ethnopharmacol. 2016;178:34-9.

Kumar V, Van Staden J. A Review of Swertia chirayita (Gentianaceae) as a Traditional Medicinal Plant. Front Pharmacol. 2016;6:308.

Berehu HM, S A, Khan MI, et al. Cytotoxic Potential of Biogenic Zinc Oxide Nanoparticles Synthesized From Swertia chirayita Leaf Extract on Colorectal Cancer Cells. Front Bioeng Biotechnol 2021;9:788527.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.